Preimplantation Genetic Testing for Aneuploidy: Challenges in Clinical Practice
Overview
Affiliations
Preimplantation genetic testing for aneuploidy (PGT-A) has been used widely during in vitro fertilization procedures in assisted reproductive centers throughout the world. Despite its wide use, concerns arise from the use of PGT-A technology in clinical decision-making. We address knowledge gaps in PGT-A, summarizing major challenges and current professional guidelines. First, PGT-A is a screening test and not a diagnostic test. Second, mosaicism is much higher in the blastocyst stage from PGT-A than had been recognized previously and a mosaic embryo may not accurately represent the genetic disease risk for future fetal disorders. Third, PGT-A was not validated clinically before use in patients; the best use of this technology for selected age-groups remains uncertain. Given these gaps, we believe that current professional policies relying on industry-self-regulation are insufficient. In the USA, the Food and Drug Administration may be the most appropriate agency to provide more definitive guidelines and regulations that are needed for better practice.
Luo S, Li X, Wang Y, Fan W, Zhang L, Quan Y Sichuan Da Xue Xue Bao Yi Xue Ban. 2024; 55(5):1288-1294.
PMID: 39507977 PMC: 11536241. DOI: 10.12182/20240960208.
Majzoub A, Viana M, Achermann A, Ferreira I, Laursen R, Humaidan P J Clin Med. 2024; 13(16).
PMID: 39201081 PMC: 11355217. DOI: 10.3390/jcm13164939.
Wu Z, Liang T, Liu Y, Ding X, Shu D Front Genet. 2024; 15:1389461.
PMID: 39175751 PMC: 11338862. DOI: 10.3389/fgene.2024.1389461.
Gudapati S, Chaudhari K, Shrivastava D, Yelne S Cureus. 2024; 16(3):e57357.
PMID: 38694414 PMC: 11061269. DOI: 10.7759/cureus.57357.
Should non-invasive prenatal testing be recommended for patients who achieve pregnancy with PGT?.
Liang Y, Li M, Fei J, Chen Z BMC Pregnancy Childbirth. 2024; 24(1):100.
PMID: 38302865 PMC: 10832195. DOI: 10.1186/s12884-024-06284-7.